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ABSTRACT 
In mammals, lactation is a rich source of nutrients and antibodies for newborn animals. 
However, millions of mothers each year experience an inability to breastfeed. Exposure to 
several environmental toxicants, including 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin (TCDD), has 
been strongly implicated in impaired mammary differentiation and lactation. TCDD and related 
polyhalogenated aromatic hydrocarbons are widespread industrial pollutants that activate the aryl 
hydrocarbon receptor (AHR). Despite many epidemiological and animal studies, the molecular 
mechanism through which AHR signaling blocks lactation remains unclear. We employed in 
vitro models of mammary differentiation to recapitulate lactogenesis in the presence of toxicants. 
We demonstrate AHR agonists directly block milk production in isolated mammary epithelial 
cells. Moreover, we define a novel role for the aryl hydrocarbon receptor repressor (AHRR) in 
mediating this response. Our mechanistic studies suggest AHRR is sufficient to block 
transcription of the milk gene ~casein. Since TCDD is a prevalent environmental pollutant that 
affects women worldwide, our results have important public health implications for newborn 
nutrition. 
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Lactation is a critical biological process in mammals that provides both nutritional and 
immune support for offspring. However, an estimated 3-6 miLUon human mothers worldwide 
suffer from impaired lactation each year (Lew et al. , 2009). Several factors contribute to milk 
production and secretion, but a growing number of studies suggest certain environmental 
toxicants negatively impact the ability of women to initiate and sustain breastfeeding (Neville 
and Walsh, 1995). For example, maternal exposure to pesticides has been associated with 
shortened duration of lactation in both the United States (Rogan et al. , 1987) and Mexico 
(Gladen and Rogan, 1995). 
One specific xenobiotic known to affect lactation is 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD). TCDD is a byproduct of natural processes, such as volcanic eruptions and forest fires, 
and industrial processes, including smelting, waste incineration, pesticide production, and 
combustion (Wong et al. , 2012). Once produced, TCDD persists in the environment and 
contaminates air, soil, and food sources (Larsen, 2006; Travis and Hattemer-Frey, 1991 ). 
Although inhalation and skin exposure occur, ingestion of contaminated food sources is the 
primary route of exposure for humans (Carpenter, 2006). With an average half-life between 7 
and 8 years in humans (Geyer et al. , 2002), TCDD is a highly stable chemical that 
bioaccumulates in fat tissue. Thus, TCDD exposure amasses and persists overtime (Consonni et 
al. , 2012). 
Previous studies have demonstrated TCDD exerts its toxicity through activation of the 
aryl hydrocarbon receptor (AHR) (Fernandez-Salguero et al., 1996). As a ligand activated 
transcription factor, AHR is restricted to the cytoplasm in its unbound state. Once activated, 
AHR translocates to the nucleus and forms a transcriptionally active complex with the AHR 
nuclear translocator (ARNT) to alter expression of specific target genes (Tijet et al., 2006). 
Although the identity of endogenous AHR activators remains controversial, several exogenous 
chemicals have been shown to target AHR (Denison and Nagy, 2003). In particular, we 
previously identified a 1,2,4-bis-aryloxadiazole, referred to as 1023, as a novel AHR agonist 
(Basham et al. , 2014; Basham et al., 2013). 
An association between AHR activation and changes in milk production has been 
observed in animal studies. Specifically, pregnant mice exposed to TCDD in vivo produced 
lower levels of the milk proteins ~-casein (Collins et al. , 2009) and whey acidic protein (W AP) 
(Vorderstrasse et al., 2004), and were unable to nutritionally support their offspring 
(Vorderstrasse et al., 2004). Moreover, exposure of pregnant rats to TCDD led to severe defects 
in mammary gland differentiation and decreased pup size fo llowing lactation (Badesha et al., 
1995; Fenton et al., 2002), suggesting TCDD exposure impaired functional development of the 
mammary gland. Together with epidemiological studies in humans, these observations support a 
strong link between AHR activation and diminished milk production. 
Despite these studies, the molecular mechanism through which AHR signaling blocks 
milk production remains unclear. Moreover, reciprocal transplant studies with AHR null 
mammary glands implicate both indirect, systemic effects and direct, cellular consequences of 
AHR signaling on alveolar differentiation (Lew et al., 2011 ). Indirectly, TCDD disrupts 
endocrine function by altering estrogen-mediated signaling (Matthews and Gustafsson, 2006; 
Safe et al., 1998). However, changes in circulating estrad iol, progesterone, or prolactin levels 
were not observed in pregnant mice after in vivo TCDD exposure (Vorderstrasse et al., 2004), 
which suggests mammary tissue may respond directly to AHR agonists. Moreover, explant 
studies, where mammary glands were cultured ex vivo under hormonal stimulation with TCDD, 
showed decreased lobuloalveolar structures (Hushka et al., 1998). Together, these studies 
suggest AHR signaling contributes to impaired lactogenesis by directly targeting mammary 
tissue. 
Based on these initial observations, we hypothesized that the epithelium had a significant 
role in mediating the response to TCDD. Thus, we aimed to identify direct epithelial 
mechanisms through which AHR activation blocks P-casein production. Using in vitro models 
of mammary morphogenesis and differentiation, we show that both environmental toxicants 
(TCDD) and novel AHR agonists (1023) block lactogenesis directly in mammary epithelial cells. 
Furthermore, we identify a new role for the aryl hydrocarbon receptor repressor (AHRR) in 
mediating this response. Our results support a model in which AHRR induction promotes 
formation of AHRR/ARNT heterodimers, which transcriptionally inhibit P-casein production. 
MATERIALS AND METHODS 
Mice. Mice were maintained following protocols reviewed and approved by the 
Univers ity of Utah Institutional Animal Care and Use Committee. 
Isolation of primary ME Cs. Organoids from the fourth inguinal mammary gland were 
isolated from virgin (8- 12-week-old) female mice and processed to single epithelial cells as 
previously described (Basham et al., 2013). 
Microarray data. Data previously generated (Basham et al., 2013) were analyzed using 
GeneSifter software (Geospiza Inc, Seattle, WA). Microarray data analyzed for this publication 
can be obtained from the Gene Expression Omnibus database 
(http://www.ncbi.nlm.nih.gov/geo/) using accession number GSE39249. 
Chemical compounds. TCDD (Cambridge Isotopes Laboratories, Inc. , Andover, MA) 
was obtained as a DMSO stock solution and used at a final concentration of l 0 nM, which is 
within the range of exposures (0.1 nM - l 00 nM) previously reported to be environmentally and 
pharmacologically relevant (Birnbaum and DeVito, 1995). 1023 was synthesized as previously 
described (Basham et al., 2013) and dissolved in OMSO at a stock concentration of 10 mM. 
I 023 was used at a final concentration of l 0 µM. which was selected based on a previous dose 
response analysis in mammary epithelial cells (Basham et al. , 2013 ), where I 023 exhibited an 
EC5o of 1.2 +/- 0.050 µM. Based on these results, 10 µM was the minimum concentration 
required to achieve maximal effect. 
HCJ 1 cell culture and induction with lactogenic hormones. HC 11 cells were 
maintained at 37°C with 5% C02 in HCl 1 culture media (RPMl (HyClone, Logan, UT), 10% 
FBS (HyClone, Logan, UT), TTS-X (Invitrogen, Carlsbad, CA), lX 
penicill in/streptomycin/glutamine (Invitrogen, Carlsbad, CA), and 10 ng/ml murine epidermal 
growth factor (EGF) (BD Biosciences, San Jose, CA)). For induction with lactogenic hormones, 
lxl 06 cells per well were seeded in 6-well tissue culture plates. Two day confluent cultures were 
washed twice with EGF-free HC 11 culture media and grown for 96 additional hours in EGF-free 
HC 11 culture media containing 5 µg/ml ovine prolactin (Sigma, St. Louis, MO) and 1 µM 
dexamethasone (Sigma, St. Louis, MO). For compound treatments, FBS was reduced to 2% 12 
hours after seeding and cells were grown with O. l % DMSO, l 0 µM I 023, or l 0 nM TCDD as 
indicated . Throughout each assay, media was replaced every 48 hours. 
AHR nuclear localization assay. In 12-well tissue culture plates, 60.000 HC 11 cells 
stably expressing pEiZ-HA-AHR were seeded onto lysine-coated glass coverslips. Cells were 
seeded in HCl I culture media containing 10% charcoal-stiipped FBS (CSFBS) (Sigma. St. 
Louis, MO). The media was replaced 12 hours later with HCl I culture media containing 2% 
CSFBS. Cells were dosed 36 hours post-plating with 0.1 % DMSO (Sigma, St. Louis. MO), l 0 
~tM 1023, or 10 nM TCDD. Samples were stained 24 hotu-s after dosing. For each condition, a 
minimum of l 00 cells per sample was scored. 
Jmmunofluorescence. For HA (4 µg/mL, Abeam, Cambridge, England, #ab9l 10) 
staining, HC I I eel Is were fixed with 4% paraformaldehyde for 15 minutes at room temperature 
(RT), washed once with 50 nM ammonium chloride (Sigma, St. Louis, MO), and permeablized 
with 0 .2% triton X-100 in PBS for 8 minutes at RT. Cells were washed once in 1 % BSA in PBS 
and blocked with 5% BSA and l % normal goat serum in PBS for 10 minutes. Following block, 
samples were incubated with primary antibody diluted in 1% BSA in PBS for 1 hour at RT. 
After primary antibody incubations, samples were washed three times with PBS and incubated 
with secondary antibody (I: 1000 in 1 % BSA in PBS Invitrogen, Carlsbad, CA, Alexa series) for 
1 hour at RT. Nuclei were stained with DAPI (50 ng/mL, Molecular Probes, Eugene, OR) for 5 
minutes at RT. Coverslips were mounted with Prolong Gold anti-fade reagent (Invitrogen, 
Carlsbad, CA). 
Microscopy. Imaging was performed using an Olympus IX81-ZDC microscope with an 
ORCAER CCD camera and Slidebook 5.0.0.24 software (Intelligent Imaging Innovations, Inc, Denver, 
CO). A 60X Plan oil objective lens was used for representative images and a 40x U-Plan objective 
lens was used for images for quantification. 
Western blot. HCl 1 cells were washed twice and scraped in I ml cold PBS. Cells were 
pelleted at 1250 x g for 5 minutes, lysed in RIPA buffer (50 mM Tris-HCL pH 8.0, 150 mM 
NaCL, 0.1 % SDS, 0.5% sodium deoxycholate, I% Triton X-100, 1 mM OTT, lX 
protease/phosphatase inhibitor cocktail), and sonicated for 20 seconds. All processing steps 
occurred at 4°C or on ice. Whole cell lysate (50 µg) was separated by 10% SDS-polyacrylamide 
gel electrophoresis and transferred to PVDF membrane (Millipore, Billerica, MA) for detection 
of ~-casein (I: 100, Santa Cruz, Dallas, TX, #sc-17969), a-tubulin (1: 1000. Sigma, St. Louis, 
MO, #T6199), hemagglutinin (HA) (1:500, Covance, Princeton, NJ, #MMS-LOlR), or ARNT 
( l :500, BD Biosciences, San Jose, CA, #611078). Integrated intensity values were measured on 
a LI-COR Odyssey Scanner (Lincoln, NE) with median background subtraction and normalized 
to a-tubulin levels. 
RNA extraction, cDNA synthesis, and real-time PCR. RNA was isolated, converted to 
cDNA, and used for real-time PCR as previously described (Basham et al., 2013). Primer 
sequences were as follows: j}-actin forward (5'-GGCTGTGCTGTCCCTGTATG-3'), j}-actin 
reverse (5'-CAAGAAGGAAGGCTGGAAAA-3'), /}-casein forward (5 '-CAA TCCCGTCCCAC 
AAAA-3 ' ), /}-casein reverse (5' -TCCAGTTTCAGTCAGTTCAAAAA-3'), a-casein forward 
(5 '-CAGAAGTGCTCTCTGTCTGTTCA-3 '), a-casein reverse (5 '-
AGCATAGCAGCAGTGAGGAAA-3'), AHR forward (5'-CTTTGCTGAACTCGGCTTGC-3'), 
AHR reverse (5'-TTGCTGGGGGCACACCA TCT-3'), CypJAJ forward (5'-
GGTTAACCATGACCGGGAACT-3'), CyplAJ reverse (5'-TGCCCAAAC 
CAAAGAGAGTGA-3 '), ARNT forward (5'-CTAAGAGACAGCTTTCAGCAGGT-3'), ARNT 
reverse (5'-AGGGTTTTGGAAGGT AAAGGAG-3'). 
Plasmids and molecular cloning. Constructs expressing an shRNA against AHR or 
ARNT were previously generated (Basham et al. , 2013) using the pLcntilox5.0-GFP vector (Cai 
et al. , 2007) provided by Dr. James Bear (University of North Carolina, Chapel Hill, NC). 
Lentiviral expression constructs were generated using the pEiZ plasmid (pHIV-Zsgreen, plasmid 
18121, Addgene, Cambridge, MA) previously described (Welm et al., 2008). For generation of 
pEiZ-HA-AHR, a mouse AHR expression plasmid (pACT AG-HA-AHR) provided by Dr. Oliver 
Hankinson (University of California, Los Angeles, CA) was used to PCR amplify HA-AHR with 
the addition of Xbal restriction sites. The following primers were used for amplification: 
0 
:> 
forward (5 '-TAAGCATCTAGAACCATGATCTTTTACCCATACGATGTTCCTG-3'), reverse 
(5'-TGCTTATCTAGAACCTCAACTCTGCACCTTGCTTAGGAAT-3'). The resulting PCR 
product was digested with Xbal and ligated into the same site in pEiZ. For generation of pEiZ-
HA-AHRR, a mouse AHRR expression plasmid (pcDNA-mAhRR) (Karchner et al. , 2002) 
provided by Dr. Mark Hahn (Woods Hole Oceanographic Institution, Woods Hole, MA) was 
used to PCR amplify AHRR with addition of an N-terminal HA tag and EcoRI restriction sites. 
The following primers were used for amplification: forward (5 '-CT AGAA TTCCCACCA TGAG 
CGT AGTCTGGGACGTCGT A TGGGTAATGA TGA TTCCGTCTGGAGAGTGT ACA-3 '), 
reverse (5'-GACGAATTCACTCTAGGGTAGGAAAATTCCATCAGAGCC-3'). The resulting 
PCR product was subcloned into the pCR®2.l-TOPO® TA vector to create Topo-HA-AHRR, 
which was then digested with EcoRl, and ligated into the same site in pEiZ. For generation of 
pEiZ-HA-AHRRmutant, site-directed mutagenesis was performed using the Strategene 
QuikChange Site-Directed Mutagenesis Kit (Strategene, La Jolla, CA) and the Topo-HA-AHRR 
plasmid according to manufactures instructions. Lys-542, Lys-583, and Lys-660 were each 
mutated to an arginine residue in separate reactions using the following primer sequences: Lys-
542-Arg sense (5 '-CACTGGA TGTGCCAA TCAGGA TOG AGAA TGAA TCTGG-3 '), Lys-542-
Arg antisense (5 '-CCAGATTCATTCTCCATCCTGA TTGGCACA TCCAGTG-3 '), Lys-583-
Arg sense (5'-CCAGGATGCACCTGAGAACAGAGCCCGACTA-3'), Lys-583-Arg antisense 
(5 '-TAGTCGGGCTCTGTTCTCAGGTGCA TCCTGG-3 '), Lys-660-Arg sense ( 5' -ACTGCAG 
AGCTCCT A TTGTTAGGCGTGAGCCTC-3 '), Lys-660-Arg antisense ( 5 '-GAGGCTCACGCC 
TAACAA T AGGAGCTCTGCAGT-3 '). Following site-directed mutagenesis, Topo-HA-
AHRRmutant was digested with EcoRI and the resulting fragment was ligated into pEiZ using 
the same site. For generation of pEiZ-HA-ARNT, an HA-tagged mouse ARNT expression 
plasmid (pACTAG-HA-ARNT) (Moffett et al., 1997) provided by Dr. Oliver Hankinson 
(University of California, Los Angeles, CA) was used to PCR amplify the HA-ARNT fragment 
with additional EcoRI restriction sites. The resulting PCR product was subcloncd into the 
pCR®2.1-TOPO® TA vector to create Topo-HA-ARNT, which was digested with EcoRl and 
ligated into the same site in pEiZ. The following plasmids for generating lentivirus have been 
previously described: pMDLg/pRRE (Dull et al. , 1998), pRSV-Rev (Dull et al., 1998), and 
pVSV-G (Clontech, Mountain View, CA). The identity of each plasmid was confirmed by 
sequencing. 
Production and titration of /entivirus. High titer lentivirus was produced, concentrated, 
and titrated as previously described (Basham et al., 2013). 
Generation of stable HCJI cell lines. For stable HC 11 cell lines expressing an shRNA 
or expression construct, l.25x l 06 cells were seeded in a I 0-cm dish, cultured for 12 hours, and 
transduced at a multiplicity of infection (MOI) of 20. For expression of HA-AHR, unsorted cells 
were used for immunofluorescence studies. For all other experiments, transduced cells were 
sorted 72 hours later based on green fluorescent protein (GFP) expression to obtain stable lines. 
RESULTS 
AHR agonists inhibit expression of milk genes in mammaty epithelial cells- To study the 
effect of AHR activation on lactation, we sought to recapitulate this process in vitro. Initially, 
we grew primary mammary epithelial cells (MECs) in our three-dimensional branching assay 
(Basham et al., 20 13) in the presence of I 023, an AHR agonist, and performed microarray 
analysis to determine differentially expressed genes. Compared to vehicle treatment (DMSO), 
cells grown with I 0 µM I 023 showed down regulation of several genes important for milk 
production, including whey acidic protein and multiple casein genes (Table 1). Given the lack of 
stromal components in this system (Basham et al., 2013; Welm et al. , 2008), these results 
suggested AHR activation blocked milk genes through a direct mechanism in mammary 
epithelial cells. 
To validate these results, we next utilized the HCJ l mammary epithelial cell line. HCl 1 
cells were clonally derived from immortalized COMMA-1 D epithelial cells (Ball et al., 1988), 
which were isolated from the mammary gland of midpregnant BALB/c mice (Danielson et al., 
1984). Importantly, HC 11 cells can be induced to differentiate with lactogenic hormones and 
produce milk proteins in culture (Ba1l et al. , 1988; Doppler et al., 1990). first, we confirmed 
that l 023 and TCDD activated AHR in this system. Since AHR translocates to the nucleus 
following activation (Denison and Nagy, 2003; Heid et al., 2000; Pollenz et al., 1994), we 
assessed AHR localization following treatment with 1023 or TCDD. Specifically, we stably 
expressed an HA-tagged AHR construct in HCI I cells and performed immunofluorescence for 
HA after 24 hours of drug treatment. We found that both 10 µM 1023 and 10 nM TCDD 
significantly increased the amount of nuclear AHR compared to DMSO (Fig. lA-B). 
Furthermore, we observed significant induction of the AHR response gene, cytochrome 
P450 l A I ( Cyp la/) (Whitlock, 1999), in parental HC l l cells following 48 hours of compound 
treatment (Supplemental Fig. I.A). Together, these experiments demonstrated 1023 and TCDD 
properly activated the AHR pathway in HCl l cells. 
Next, we induced HC 11 cells with lactogenic hormones and tested the effect of AHR 
activation on f3-casein and a-casein expression. Using this assay, cells grown in the presence of 
IO µM l 023 or l 0 nM TCDD failed to produce the milk protein, P-casein, compared to vehicle 
treated cells (DMSO) (Fig. l C). In agreement with our microarray data from primary MECs, 
mRNA expression of both /]-casein and a-casein were also inhibited (Fig. I 0 and Supplemental 
Fig. lB), suggesting a transcriptional mechanism of gene regulation. 
Previously, we identified and validated AHR as the biological target of 1023 (Basham et 
al., 2013). To confirm the observed inhibition of 13-cascin protein production was dependent on 
the AHR pathway, we used lentiviral constructs to generate stable HCI I cell lines expressing 
either a non-specific shRNA (Control) or an shRNA against AHR (shAHR # 1 and shAHR #2). 
In cells with ~50% AHR knockdown (Supplemental Fig. IC), we observed a partial rescue in 13-
casein expression in the presence of AHR agonists (Fig. l D, Supplemental Fig. 1 D). These 
results suggested l 023 and TCDD inhibited 13-casein production in mammary epithelial cells 
through AHR pathway activation. 
The aryl hydrocarbon receptor repressor is sufficient to inhibit /]-casein - Given our data 
in both primary MECs and mammary HCl 1 cells, we hypothesized AHR activation blocked /J-
casein production through a transcriptional mechanism. Moreover, we became interested in a 
potential role for AHRR in mediating this process. As a direct target of activated AHR (Mimura 
et al., 1999), AHRR is highly upregulated in primary MECs treated with I 023 (Basham et al., 
2013) and has a known role as a transcriptional repressor. Specifically, AHRR shares high 
amino acid identity with the N-terminal portion of AHR, which contains both the basic helix-
loop-helix (bHLH) and Per-ARNT-Sim '·A" (PAS-A) domains (Mimura et al., 1999). These 
regions of the AHR protein facilitate DNA binding and ARNT dimerization, which allows 
AHRR to form a heterodimer with ARNT and bind xenobiotic-responsive elements (XREs) in 
the promoter region of AHR target genes. Subsequent recruitment of a corepressor complex, 
which includes ANKRA2, HDAC4, and HDAC5, inhibits transcription of AHR target genes 
(Mimura et al., 1999; Oshima et al., 2007). 
To test the effect of AHRR on f3-casein expression, we first stably expressed a lentiviral 
HA-tagged AHRR construct in HCI I cells. We confirmed overexpression (Fig. 2A) and 
validated the construct by measuring a well-characterized AHR response gene, Cyp IA I. 
Compared to control transduced cells, overexpression of AHRR decreased induction of Cyp/A I 
after 48 hours of treatment with 10 µM 1023 (Fig. 28). These results verified our tagged AHRR 
construct interacted with ARNT to functionally repress known target genes. 
Next, we tested whether AHRR expression was sufficient to block P-casein production in 
the absence of AHR agonists. In HCI l cells induced with lactogenic hormones, and without 
exposure to AHR agonists, 13-casein production was repressed at both the mRNA (Fig. 2C) and 
protein level (Fig. 20) in cells expressing HA-AHRR compared to control cells. These results 
demonstrated the presence of AHRR was sufficient to block 13-casein expression. 
AHRR contains a transcriptional repression domain within its C-terminal region, which 
consists of three conserved small ubiquitin-like modifier (SUMO)ylation sites at Lys-542, Lys-
583, and Lys-660. Previous studies demonstrated these lysine residues are modified by SUM0-1 
to facilitate interaction between AHRR and its corepressor complex (Oshima et al., 2009). To 
genetically test the requirement of this interaction for AI-IRR to inhibit P-casein production, we 
mutated all three lysine residues to arginine (HA-AHRRmutant). Previously, these mutations in 
AHRR have been shown to allow interaction between AHRR and ARNT, but prevent interaction 
between AHRR and its corepressor complex (Oshima et al., 2009). Compared to HCl I cells 
overexpressing wild-type Al-IRR, overexpression of the SUMOylation mutanl signficantly 
rescued 13-casein production (Fig. 2E), suggesting AHRR requires interaction with its 
corepressor complex to inhibit lactogenesis. 
ARNT is required for fl-casein production in mammary epithelial ceffs- To elucidate the 
mechanism through which AHRR inhibits milk production, we examined the role of its major 
binding partner, ARNT, during normal lactation. Stable HC 11 cell lines expressing a 
nonspecific lentiviral shRNA (Control) or a lentiviral shRNA against ARNT (shARNT # 1 or 
shARNT #2) were generated (Fig. 3A-B). Following induction with lactogenic hormones, 
knockdown of ARNT inhibited P-casein expression at both the mRNA (Fig. 3C) and protein 
level (Fig. 3D), and expression of a-casein mRNA (data not shown). As loss of AHR in the 
absence of any chemical agonists had no effect on P-cascin production in HC 11 cells (Fig. lD), 
these results implicated an independent role for ARNT during milk production. 
Overexpression of ARNT rescues fl-casein production in the presence of AHR agonists-
Based on our results, we hypothesized ARNT participated in a transcriptionally active complex 
to promote expression of milk genes, such as P-casein, during lactogcnesis. Furthermore, since 
ARNT was required for lactogenesis, we speculated AHRR might inhibit milk production 
through competitive interactions with ARNT. To test this hypothesis, we ovcrcxpressed ARNT 
prior to treatment with AHR agonists and measured P-casein levels to assess milk production. 
We reasoned overexpression of ARNT would promote transcriptionally active complexes and 
restore P-casein levels in the presence of AHR agonists. In HC I I cells stab ly overexpressing a 
lentiviral HA-ARNT construct (Fig. 4A), we found P-casein expression partially restored in the 
presence of both I 0 µM 1023 and 10 nM TCDD compared to control cells (fig. 48). These 
results support a model in which AHRR blocks production of P-casein by acting as a 
transcriptional reprcssor to inhibit ARNT signaling. 
DISCUSSION 
Using an epithelial-based model of mammary lactation, we demonstrate AHR agonists 
directly block P-casein expression. Specifically, we showed AHRR, a robust downstream target 
of AHR signaling, was sufficient to inhibit the production of P-casein. Although well studied in 
the context of AHR activation, AHRR is also induced by other toxic insults. In particular, recent 
studies showed cigarette smoking, including secondhand exposure, caused significant 
demethylation and increased expression of AHRR (Philibert et al., 2012; Shenker et al. , 2013). 
As women who smoke have consistently been shown to produce significantly less milk volume 
(Hopkinson et al., 1992; Vio et al., 1991) and breastfeed for a shorter duration (Andersen and 
Schioler, 1982; Hakansson and Carlsson, 1992; Schulte-Hobein et al., l 992; Vio, Salazar and 
Infante, 199 L; Whichelow, 1979), our results provide a potential molecular mechanism through 
which this toxicity occurs. 
Following induction, AHRR forms a heterodimer complex with ARNT (Evans et al. , 
2008). As loss of ARNT significantly blocked P-casein production in mammary epithelial cells, 
our results implicate an important role for ARNT during lactation. These observations are 
consistent with the phenotype observed in conditional ARNT knockout mice, where ARNT 
deletion using the MMTV-Cre transgene resulted in impaired mammary function (Le Provost et 
al. , 2002). Specifically, loss of ARNT led to incomplete alveolar development, smaller litter 
sizes, and 60% of dams that could not support their pups. 
However, inactivation of ARNT using W AP-Cre resulted in normal mammary 
differentiation during pregnancy (Le Provost et al., 2002). Furthermore, transplantation of 
ARNT null mammary epithelium generated using MMTV-Cre into wild-type recipients 
normalized alveolar development (Le Provost et al. , 2002). Although inconsistent with initial 
studies and our current findings, these incongruent results may be explained by differences in 
methodology. Specifically, W AP-Cre reduced ARNT levels in 80% of the mammary epithelium 
(Le Provost et al. , 2002; Walton et al., 2001), resulting in residual ARNT expression that may 
facilitate normal development. Jn reciprocal transplant studies, the high selective pressure of 
transplantation may have induced compensation from other ARNT family members, including 
ARNT2. Expressed in the mammary gland (Martinez et al. , 2008), ARNT2 is known to form 
functional complexes with AHR (Hirose et al., 1996) and may be capable of contributing to 
mammary development. Further in vivo studies will be required to explain these differences. 
Our experiments with AHRR and ARNT suggest a model in which ARNT promotes milk 
production under lactogenic conditions (Fig. 5). As a bHLH-PAS family member, ARNT 
requires dimerization to form a functional transcription complex. Although ARNT is known to 
interact with multiple proteins, we hypothesize that hypoxia inducible factor-1 a (HTFI a) or 
single-minded 2 (SIM2) interact with ARNT to promote lactation. In previous studies, 
conditional knockout of ARNT prevented induction of known HIF I a target genes (Tomita et al. , 
2000), suggesting ARNT is critical for HIF I a signal transduction. Additionally, deletion of 
HIF la in the mammary epithelium resulted in severe differentiation defects and failed lactation 
(Seagroves et al. , 2003). Previous studies with SIM2 also support its potential role in 
cooperating with ARNT to regulate lactation. With SIM2 overexpression, precocious production 
of P-casein and WAP occurred in vitro and in vivo, and chromatin immunoprecipitation (ChTP) 
experiments showed S1M2 associated with the P-casein promoter. Conversely, loss of SIM2 
inhibited milk production (Wellberg et al., 20 I 0). Taken together, these experiments strongly 
implicate a role for HIFla or STM2 in promoting ARNT-mediated lactogenesis. 
In response to toxic stimuli, our data suggest that AHRR/ARNT hcterodimers form and 
arc sufficient to block lactation. One potential mechanism of AHRR repression under these 
conditions is ARNT sequestration. Competition for a limited pool of ARNT has been observed 
previously, where ARNT availability regulated AHR signaling through HIFla (Gradin et al., 
1996) and SIMI (Probst et al. , 1997; Woods and Whitelaw, 2002). However, our experiments 
using an AHRR repression mutant that could bind ARNT, but not recruit a corepressor complex, 
suggest this is not the dominant mechanism. Rather, our results favor a model in whkh AHRR 
SUMOylation and subsequent recruitment of a corepressor complex that includes ANKRA2, 
HDAC4, and HD.ACS blocks transcription of genes important for milk production. further 
experiments will be needed to determine whether activating ARNT complexes and repressive 
AHRR/ARNT heterodimers bind the same DNA response elements. Additionally, these studies 
will help determine whether ARNT-mediated complexes bind directly in the promoter region of 
milk target genes or whether they control activity of an intermediate factor(s). We have not 
identified AHR consensus elements within the mouse or human P-casein promoters, and since 
several milk genes are affected by AHR signaling it is possible global rather than direct 
pathways attenuate lactation. Further studies will be necessary to determine the targets of AHR 
signaling that modulate lactogenesis. 
Our data demonstrate AHR signaling directly disrupts milk protein production in isolated 
mammary epithelial cells. Since industrial waste is one of the main sources of TCDD and other 
related polyhalogenated aromatic hydrocarbons, human exposure to these toxicants is highest in 
industrialized countries (Schecter et al., 2006a). However, acute exposure has occurred m 
several distinct populations worldwide, including exposure to Agent Orange herbicide m 
Vietnam (Schecter et al. , 2006b), indigenous Canadian Inuit populations who consume 
contaminated marine species (Ayotte et al., 1996), and people living in Seveso, Italy during the 
1976 industrial explosion (Warner et al., 2002), among others. Given the prevalence of these 
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environmental pollutants and their ability to bioaccumulate over time, our study has substantial 
implications on public health, particularly with regard to the ability of women to breastfeed. 
Thus, future efforts to monitor TCDD exposure levels, analyze epidemiological data, and 
elucidate the molecular mechanism downstream of AHRR are needed to address this problem. 
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FIGURE LEGENDS 
FIG. 1. AHR activation blocks milk production in HCl 1 mammary cells. A, Mammary HCl l 
cells were transduced with lentivirus to generate a cell line stably expressing HA-tagged AHR. 
HCl l cells expressing HA-tagged AHR were treated with vehicle control (DMSO), 10 µM 1023, 
or I 0 nM TCDD for 24 hours. lmmunofluorescen.ce for HA was performed to measure nuclear 
translocation of AHR. Dashed white line defines nuclei. Scale bar = 10 µm. B, Quantification 
of AHR nuclear translocation. An **** indicates a statistically significant difference compared 
to vehicle treated cells (p ~ 0.000 l). C, Mammary HC 11 cells were treated with vehicle control 
(DMSO), I 0 µM I 023, or 10 nM TCDD and induced with lactogenic hormones (LH) to produce 
milk proteins. HC 11 cell lysates were probed for p-casein and a.-tubulin (control). D, /J-casein 
mRNA levels were measured in the same assay by RT-PCR and normalized to /J-actin 
expression. Results are shown as normalized mean f3-casein expression (± SEM). An **** 
indicates a statistically significant difference compared to vehicle treated cells (p ~ 0.000 I). E, 
Lentiviral shRNA constructs (shAHR#l and shAHR#2) were used to stably knockdown AHR 
expression HCJ J cells. Stable HCI I cell lines were treated, induced, and probed for p-casein 
and p-actin (control) as described above. Abbreviations: HA, hemagglutinin; TCDD, 2,3 ,7,8-
Tetrachlorodibenzo-p-dioxin; LH, lactogenic hormones; AHR, aryl hydrocarbon receptor. 
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FIG. 2. AHRR is sufficient to block milk production in HCl l mammary cells. HCl l cells were 
transduced with lentivirus to generate cell lines stably expressing HA-tagged AHRR (pEiZ-HA-
AHRR) or a vector control (pEiZ). A, Western blot of lysates from stable cell lines probed for 
HA and cx.-tubulin (control). B, Stable HCll cell lines were treated for 48 hours with vehicle 
control (DMSO) or 10 µM 1023. JI i t mRNA levels were measured by RT-PCR and 
normalized to f3-actin expression. Results are shown as normalized mean C: D l: i expression 
(± SEM). An **** indicates a statistically significant difference compared to treated vector 
control cells (p ~ 0.0001). C, Stable HCl I cell lines were induced with lactogenic hormones 
(LH) to produce milk proteins. f3-casein mRNA levels were measured by RT-PCR and 
normalized to f3-actin expression. Results are shown as normalized mean f3-casein expression(± 
SEM). An **** indicates a statistically significant difference compared to treated vector control 
cells (p ~ 0.0001). D, Cell lysates were probed for 0-casein and a.-tubulin (control). E, An 
HCl 1 cell line was generated to express AHRR mutated to prevent SUMOylation in the C-
terminal region (HA-AHRRmutant). All stable cell Lines were induced with LH and probed for 
~-casein and a.-tubulin (control) as before. Abbreviations: HA, hemagglutinin; AHRR, aryl 
hydrocarbon receptor repressor; LH, lactogenic hormones. 
FIG. 3. ARNT is required for milk production in HCl I mammary cells. A, Lentiviral shRNA 
constructs (shARNT#l and shARNT#2) were used to stably knockdown ARNT expression in 
HC 11 cells. ARNT expression was measured by RT-PCR, normalized to f3-actin expression, and 
compared to HC 11 cells stably expressing a control shRNA (Control). Results are shown as 
normalized mean ARNT expression (± SEM). An * indicates a statistically significant difference 
compared to control shRNA cells (p ::; 0.05). B, ARNT protein levels were measured in cell 
lysates from stable lines. Western blot of lysates probed for ARNT and a.-tubulin (control) . C, 
Stable HCI 1 cell lines were induced with lactogenic honnones (LH) to produce milk proteins. 
/)-casein mRNA levels were measured by RT-PCR and nonnalized to j)-actin expression. 
Results are shown as nonnalized mean /)-casein expression (± SEM). An **** indicates a 
statistically significant difference compared to treated control cells (p ~ 0.000 l ) . D, Western 
blot of lysates probed for B-casein and a.-tubulin (control). Abbreviations: ARNT, aryl 
hydrocarbon receptor nuclear translocator; LH, lactogenic hormones. 
FIG. 4. ARNT overexpression rescues milk production in the presence of AHR agonists. A, A 
HA-tagged ARNT construct (pEiZ-HA-ARNT) was stably expressed in mammary HC l 1 cells 
using lentiviral transduction. An empty expression vector (pEiZ) was used to create a stable 
control HCl I cell line. Western blot oflysates probed for HA and a.-tubul in (control). B, Stable 
HCll cell lines were treated with vehicle control (DMSO), 10 µM 1023, or 10 nM TCDD and 
induced with lactogenic hormones (LH) to produce milk proteins. Western blot of lysates 
probed for P-casein and a.-tubulin (control). Abbreviations: HA, hemagglutinin; ARNT, aryl 
hydrocarbon receptor nuclear translocator; LH, lactogenic hormones; TCDD, 2J,7,8-
tetrachlorodibenzo-p-dioxin. 
FIG. 5. Working model for the mechanism through which AHR activation blocks milk 
production in mammary epithelial cells. (Right) In the absence of AHR agonists, we propose 
ARNT signaling promotes milk production during lactogenic stimulation. (Left) In the presence 
of AHR agonists, AHR translocates to the nucleus and forms a heterodimer with ARNT. 
AHR/ ARNT heterodimers bind XRE sequences to increase transcription of AHR target genes, 
including AHRR. Once induced, AI-IRR competes with AHR for interaction with ARNT and 
forms a transcriptionally repressive complex, which we propose inhibits expression of milk 
proteins. Dashed lines indicate aspects of the model proposed by the current data. 
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